For pharmaceutical quality leaders, ensuring readiness for FDA inspections is critical to maintaining compliance and avoiding regulatory penalties. Pre-inspection audits, such as mock FDA inspections, are an essential tool for identifying potential compliance gaps, strengthening quality systems, and preparing teams to handle the rigors of an actual inspection. NSF’s expertise in this area makes it a trusted partner for pharmaceutical companies aiming to achieve and maintain regulatory excellence.
Why mock inspections are an essential tool for pharma leaders
Is your company ready for its next regulatory inspection? NSF specialists can conduct a thorough pre-inspection audit to help you identify areas for improvement and ensure you meet all necessary compliance standards
Promoted Content
You may also like
Analysis
Inspection readiness should be part of normal operations
Read moreFor routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone
Trending Articles
You may also like
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone
Analysis
Quality culture becomes visible during an inspection
Quality culture can sound intangible, but investigators encounter evidence of it throughout an inspection. Is your quality system ready for regulatory scrutiny? Former FDA investigator Dr. Julia Marré shares practical guidance on quality culture, site preparation and effective Form FDA 483 responses